Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

These data suggest that 1L NALIRIFOX provides efficacy benefits for patients with mPDAC without compromising HRQoL or PS compared with Gem + NabP.

Authors

Institutions

Publication Details

Journal
ESMO Open
Published
2025-08-01
DOI
https://doi.org/10.1016/j.esmoop.2025.105534
Citations
2
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
2.09

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

Fawzi Benzaghou, Roberto Pazo-Cid, Andrew Scott Paulson, Zev A. Wainberg et al.
2 citations
ESMO Open
Pancreatic and Hepatic Oncology Research
2.09
article

Health-related quality of life and performance status with NALIRIFOX versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma: results from the NAPOLI 3 trial

Fawzi Benzaghou, Roberto Pazo-Cid, Andrew Scott Paulson, Zev A. Wainberg, E. Van Cutsem, Davide Melisi, Christelle de la Fouchardière, T. Macarulla, Fiona Maxwell, Tanios Bekaii‐Saab, Richard Hubner, Thorsten Oliver Goetze, Eileen Mary O'Reilly, L. Zhang, Shubham Pant, Woo Jin Lee, Sreenivasa R Chandana
article en
2 citations

Abstract

These data suggest that 1L NALIRIFOX provides efficacy benefits for patients with mPDAC without compromising HRQoL or PS compared with Gem + NabP.

ESMO OpenVol. 10(8)
Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), University of California, Los Angeles (US), Texas Oncology (US), Universitair Ziekenhuis Leuven (BE), Ipsen (United Kingdom) (GB), Azienda Ospedaliera Universitaria Integrata Verona (IT), Los Angeles Medical Center (US), Centre Léon Bérard (FR), Hospital Universitario Miguel Servet (ES), Masaryk Memorial Cancer Institute (CZ), National Cancer Center (KR), Mayo Clinic in Arizona (US), Vall d'Hebron Hospital Universitari (ES), The Christie NHS Foundation Trust (GB), Krankenhaus Nordwest (DE), Ipsen (United States) (US), Hematology Oncology Consultants (US), Vall d'Hebron Institute of Oncology (ES), KU Leuven (BE)
Ipsen Biopharmaceuticals, Ipsen
Openalex Percentile: Top 11%
Pancreatic and Hepatic Oncology Research
2.09
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.